Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in astrocytic gliomas and their correlation to cell proliferation

Gen Diagn Pathol. 1996 May;141(5-6):339-44.

Abstract

The aim of this report was to investigate the expression of the p53 and mdm-2 oncoproteins in astrocytic gliomas and to assess their interrelation to proliferating activities. Using monoclonal antibodies directed against p53 and mdm-2, these proteins were stained immunohistochemically in 60 astrocytic brain tumors with different histologic grade. Positive p53 stained nuclei were detected in 25.4% of the tumor cases. Mdm-2 staining products were only localized in 10.5% of specimens. Significant correlations could be found between p53, MIB-1, PCNA and mitotic index on the one hand, and tumor grade on the other hand. There were no clear relations between mdm-2 expression and proliferation markers. The grade of ploidy has a lower priority for the proliferating activity. In most cases mdm-2 immunoreactivity was strongly associated with a low or negative p53 expression.

MeSH terms

  • Astrocytoma / chemistry*
  • Astrocytoma / immunology
  • Biomarkers, Tumor / biosynthesis*
  • Biomarkers, Tumor / chemistry
  • Cell Division
  • Humans
  • Immunohistochemistry
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / chemistry
  • Nuclear Proteins*
  • Proto-Oncogene Proteins / biosynthesis*
  • Proto-Oncogene Proteins / chemistry
  • Proto-Oncogene Proteins c-mdm2
  • Tumor Suppressor Protein p53 / biosynthesis*
  • Tumor Suppressor Protein p53 / chemistry

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2